Hsbc Holdings PLC Senseonics Holdings, Inc. Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.94 - $1.94 $9,650 - $19,917	-10,267 Reduced 32.86%	20,975 $21,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $455 - $1,098	296 Added 0.96%	31,242 $61,000
Q4 2021 Feb 11, 2022	BUY	$2.58 - $3.91 $45,002 - $68,202	17,443 Added 129.18%	30,946 $82,000
Q3 2021 Nov 12, 2021	SELL	$2.77 - $4.05 $15,944 - $23,311	-5,756 Reduced 29.89%	13,503 $45,000
Q2 2021 Aug 13, 2021	BUY	$1.71 - $4.14 $32,932 - $79,732	19,259 New	19,259 $73,000
Q4 2019 Feb 14, 2020	SELL	$0.83 - $1.3 $10,408 - $16,302	-12,540 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.94 $12,163 - $24,327	12,540 New	12,540 $12,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.